694 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Thursday’s Close
LLY Eli Lilly and Company $105.71 $113.53B N/A
Article Searches
Biogen (BIIB) Q2 Earnings: Will the Stock Disappoint? http://www.zacks.com/stock/news/223578/biogen-biib-q2-earnings-will-the-stock-disappoint?cid=CS-ZC-FT-223578 Jul 15, 2016 - Will Tecfidera scrips and sales recover enough to boost Biogen's (BIIB) performance in the second quarter?
Lilly (LLY) Beats on Q2 Earnings & Revenue, Maintains View http://www.zacks.com/stock/news/224980/lilly-lly-beats-on-q2-earnings-revenue-maintains-view?cid=CS-ZC-FT-224980 Jul 26, 2016 - New products in Lilly's (LLY) portfolio contributed to volume growth in the quarter.
Eli Lilly & Co. (LLY) John C. Lechleiter on Q2 2016 Results - Earnings Call Transcript http://seekingalpha.com/article/3991737-eli-lilly-and-co-lly-john-c-lechleiter-q2-2016-results-earnings-call-transcript?source=feed_sector_healthcare Jul 26, 2016 - Eli Lilly & Co. (NYSE:LLY)Q2 2016 Earnings CallJuly 26, 2016 9:00 am ETExecutivesJohn C. Lechleiter - Chairman, President & Chief Executive OfficerPhilip Johnson - Vice President, Investor RelationsDe
Eli Lilly (LLY) May Beat Q2 Earnings: Will the Stock Gain? http://www.zacks.com/stock/news/224276/eli-lilly-lly-may-beat-q2-earnings-will-the-stock-gain?cid=CS-ZC-FT-224276 Jul 21, 2016 - The combination of Lilly's Zacks Rank #3 and +1.18% ESP makes us very confident in looking for a positive earnings beat on Jul 26.
Medical Stocks Reporting Early Next Week: GILD, LLY & More http://www.zacks.com/stock/news/224592/medical-stocks-reporting-early-next-week-gild-lly-more?cid=CS-ZC-FT-224592 Jul 22, 2016 - How will medical stocks Gilead, Eli Lilly and others fare in Q2?
Merck (MRK) Updates Outlook Following Q2 Earnings Beat http://www.zacks.com/stock/news/225848/merck-mrk-updates-outlook-following-q2-earnings-beat?cid=CS-ZC-FT-225848 Jul 29, 2016 - Merck (MRK) surpassed Q2 earnings expectations by a penny while revenues were in-line with estimates.
AbbVie (ABBV) Beats on 2Q Earnings, Revenues, Ups View http://www.zacks.com/stock/news/225863/abbvie-abbv-beats-on-2q-earnings-revenues-ups-view?cid=CS-ZC-FT-225863 Jul 29, 2016 - AbbVie (ABBV) raised its 2016 outlook following its Q2 earnings and revenue beat.
Top 7 Research Reports for July 29, 2016 http://www.zacks.com/research-daily/87192/top-7-research-reports-for-july-29-2016?cid=CS-ZC-FT-87192 Jul 29, 2016 - Top 7 Research Reports for July 29, 2016
Novo Nordisk's Diabetes Unit Strong; Generic Pressure Stays http://www.zacks.com/stock/news/252549/novo-nordisks-diabetes-unit-strong-generic-pressure-stays?cid=CS-ZC-FT-252549 Mar 13, 2017 - We issued an updated research report on Novo Nordisk (NVO) on Mar 9, 2017.
Merck Closes Acquisition of Controlling Stake in Vallee S.A http://www.zacks.com/stock/news/253862/merck-closes-acquisition-of-controlling-stake-in-vallee-sa?cid=CS-ZC-FT-253862 Mar 23, 2017 - Merck & Co., Inc. (MRK) has completed the previously announced acquisition of a controlling stake in Vallee S.A., a leading privately held producer of animal health products in Brazil.

Pages: 12345678910...70

<<<Page 5>